This trial is completed!
Search for a recruiting clinical trial for your condition
Your journey
1What's a trial
4Get in touch
More info
You can access this
clinical trial
if you have
Influenza A or Influenza B
and you are
This is a second phase trial assessing
efficacy and side effects of the new treatment.
Show me locations

The purpose

This randomized, open-label, multicenter phase 2 trial will assess the safety, efficacy, and pharmacokinetics (PK) of anti-influenza plasma in subjects with influenza A or B. Hospitalized subjects with influenza A or B that have either a low oxygen level or a high respiratory rate will be eligible for study participation. This study will enroll adults, children and pregnant women.

Provided treatments

  • Biological: Anti-Influenza Immune Plasma
  • Drug: Standard Care

Locations near you

Unfortunately, there are no recruiting locations near you. Please check the list with all locations below.
Tris trial is registered with FDA with number: NCT01052480. The sponsor of the trial is National Institute of Allergy and Infectious Diseases (NIAID) and it is looking for 98 volunteers for the current phase.
Official trial title:
A Randomized, Open-Label, Phase 2, Multicenter Safety and Exploratory Efficacy Study of Investigational Anti-Influenza Immune Plasma for the Treatment of Influenza (IRC002)